Related Experiment Videos
Polysaccharide film-coating process for freely swellable hydrogels
G Coppi1, V Iannuccelli, R Cameroni
1Department of Pharmaceutical Sciences, University of Modena, Italy.
Pharmaceutical Development and Technology
|September 22, 1998
Summary
A novel drug delivery device using a poly(vinyl alcohol) (PVA) hydrogel matrix and calcium alginate membrane was developed. This design prevents membrane fractures, enabling controlled diltiazem hydrochloride release for targeted intestinal delivery.
Area of Science:
- Materials Science
- Drug Delivery Systems
- Polymer Chemistry
Background:
- Controlled drug release is crucial for therapeutic efficacy and patient compliance.
- Hydrogel-based systems offer biocompatibility and tunable release profiles.
- Preventing membrane integrity issues in drug delivery devices is a significant challenge.
Purpose of the Study:
- To design and fabricate an intramembrane freely swellable matrix device for controlled drug release.
- To investigate the influence of a calcium alginate membrane on drug release kinetics.
- To evaluate the potential for targeted drug delivery to the small intestine.
Main Methods:
- Fabrication of a crosslinked poly(vinyl alcohol) (PVA) hydrogel matrix loaded with diltiazem hydrochloride.
- Coating the PVA matrix with a calcium alginate membrane via ionotropic gelation.
- Characterization of membrane thickness and structure.
- In vitro drug release studies in simulated gastric and intestinal fluids.
Main Results:
- The fabricated device featured a void space between the PVA matrix and calcium alginate membrane.
- Membrane thickness increased with coating time, influencing drug release.
- Sustained and constant drug release rates were achieved after an initial burst phase.
- The device demonstrated pH-dependent drug release, with higher delivery in intestinal fluid.
Conclusions:
- The designed intramembrane freely swellable matrix device effectively controls drug release by maintaining membrane integrity.
- The calcium alginate membrane acts as a rate-controlling factor, enabling tunable drug delivery.
- The device shows promise for targeted drug delivery to the small intestine due to its pH-dependent release characteristics.